Tower Research Capital LLC (TRC) - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 2 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$27,757
+17.5%
3,474
+27.9%
0.00%0.0%
Q2 2023$23,629
+214709.1%
2,716
-29.9%
0.00%
Q1 2023$110.0%3,876
+22.0%
0.00%
Q4 2022$11
-100.0%
3,176
-31.0%
0.00%
-100.0%
Q3 2022$37,000
+105.6%
4,605
+99.3%
0.00%
Q2 2022$18,000
-85.8%
2,311
-77.8%
0.00%
-100.0%
Q1 2022$127,000
+32.3%
10,418
+32.6%
0.00%
-50.0%
Q4 2021$96,000
+1271.4%
7,856
+1051.9%
0.00%
Q3 2021$7,000
-58.8%
682
-64.6%
0.00%
Q2 2021$17,000
-59.5%
1,929
-53.2%
0.00%
-100.0%
Q1 2021$42,000
+133.3%
4,125
+46.8%
0.00%0.0%
Q4 2020$18,0002,8100.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
WOODSTOCK CORP 22,253$514,2670.06%
MASSMUTUAL TRUST CO FSB/ADV 108$2,4960.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders